News
RFL
2.080
+1.46%
0.030
Weekly Report: what happened at RFL last week (0203-0207)?
Weekly Report · 5d ago
Weekly Report: what happened at RFL last week (0127-0131)?
Weekly Report · 02/03 09:06
Wednesday Sector Laggards: Real Estate, Consumer Services
NASDAQ · 01/29 16:58
Weekly Report: what happened at RFL last week (0120-0124)?
Weekly Report · 01/27 09:06
Weekly Report: what happened at RFL last week (0113-0117)?
Weekly Report · 01/20 09:06
Weekly Report: what happened at RFL last week (0106-0110)?
Weekly Report · 01/13 09:06
Weekly Report: what happened at RFL last week (1230-0103)?
Weekly Report · 01/06 09:06
Weekly Report: what happened at RFL last week (1223-1227)?
Weekly Report · 12/30/2024 09:06
Weekly Report: what happened at RFL last week (1216-1220)?
Weekly Report · 12/23/2024 09:06
Weekly Report: what happened at RFL last week (1209-1213)?
Weekly Report · 12/16/2024 09:06
Rafael Holdings: Strategic Developments and Financial Insights
TipRanks · 12/12/2024 03:52
RAFAEL HOLDINGS, INC. FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended October 31, 2024
Press release · 12/11/2024 20:44
Rafael Holdings, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Updates on Planned Merger with Cyclo Therapeutics
Barchart · 12/11/2024 16:18
*Rafael Holdings 1Q R&D Expenses Were $1.3M >RFL
Dow Jones · 12/11/2024 12:11
Rafael Holdings reports Q1 EPS (37c) vs (15c) last year
TipRanks · 12/11/2024 12:06
Rafael Holdings GAAP EPS of -$0.37
Seeking Alpha · 12/11/2024 12:04
*Rafael Holdings Currently Evaluating Other Operating Entities >RFL
Dow Jones · 12/11/2024 12:04
*Rafael Holdings Had Cash, Cash Equivalents, Marketable Securities at Oct 31 of $54.3M >RFL
Dow Jones · 12/11/2024 12:04
*Rafael Holdings Currently Evaluating Portfolio of Assets >RFL
Dow Jones · 12/11/2024 12:04
*Rafael Holdings Targets Vote on Cyclo Therapeutics Merger in 1Q>RFL
Dow Jones · 12/11/2024 12:03
More
Webull provides a variety of real-time RFL stock news. You can receive the latest news about Rafael Holdings through multiple platforms. This information may help you make smarter investment decisions.
About RFL
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. Its segments include Healthcare, Infusion Technology and Real Estate. It holds a majority equity interest in LipoMedix Pharmaceuticals Ltd. (a clinical-stage pharmaceutical company), Barer Institute Inc. (a preclinical cancer metabolism research operation), and a majority interest in Cornerstone Pharmaceuticals, Inc. (a cancer metabolism-based therapeutics company). It holds a majority interest in Rafael Medical Devices, LLC., an orthopedic-focused medical device company, and a majority interest in Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their cannabis offerings enabling them to bring to market predictable versions by utilizing Day Three's pharmaceutical-grade technology and innovation like Unlokt. Its investments include Cyclo Therapeutics Inc. (developing Trappsol Cyclo). It holds a portion of a commercial building in Israel.